Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2020.0299


Single cell transcriptomic and cell-to-cell validity-guided therapy.

Konstantinos Bramis, MD.


Tumor heterogeneity has been established as the most crucial and independent prognostic and predictive target for the unmet need of the development of novel targeted drugs to successfully treat extensive genomic variability.
Colorectal cancer recommendation-based resection of liver metastasis represents a prime paradigm for the expansion of genome and transcriptome NGS. Indeed intratumor heterogeneity of primary and metastatic tumor completed with matched NGS of circulating cell-free DNA can reveal the spatiotemporal dynamics of CRC genomic long evolution.
Transcriptional and potentially clinical implications including discussion of new CRC oncotargets and drugs, as well as dynamic predictive biomarkers and expansion of available drug list are discussed.

(Citation: Gastric & Breast Cancer 2020; 15(1): 69-82)


You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 10 January 2020